Teriparatide (recombinant human parathyroid hormone [1‐34]) increases foot bone remodeling in diabetic chronic Charcot neuroarthropathy: a randomized double‐blind placebo‐controlled study
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Diabetes"
DOI: 10.1111/1753-0407.12902
Abstract: Currently, there is no consensus regarding the medical treatment of chronic Charcot neuroarthropathy (CN) of foot, except for effective off‐loading. Because tarsal bones are predominantly trabecular, teriparatide may improve the macroarchitecture of foot bones in… read more here.
Keywords: recombinant human; charcot neuroarthropathy; chronic charcot; human parathyroid ... See more keywords